Latigo Biotherapeutics, Inc.

Latigo Biotherapeutics, Inc.

NNASDAQ:LTGO
13.76
USD
+1.16
(+9.21%)
-2.12EPS
1.11BMarket Cap
Mar 03Next Earn

Latigo Biotherapeutics, Inc. Documents

Q2 FY2026 · Earnings release

September 3, 2026 · 5 pages

Read Latigo Biotherapeutics, Inc.'s results firsthand

Preview the first 2 pages of this earnings release
Create a free account to start reading

Full documents are included with Professional

Q2 FY2026 documents